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Patients with unstable angina and intracoronary thrombus are more likely
to have lower procedural success, higher abrup1 closure risk, and worse in-
hospital clinical outcome. Patients with unstable angina and preprocedural
intracoronary thrombus represent a high risk group for which new strategies
need to be developed to improve the outcome of percutaneous interven-
tions.
Performance of Coronary Angioplasty in Patients
with Multivessel Coronary Artery Disease:
Observations from the Bypass Angioplasty
Revascularization Investigation (BARI)
David O. Williams, Sheryl F. Kelsey, James E. Bost, George Sopko, Robert L. Frye,
Katherine M. Detre, BARI Investigators. Rhode Island Hospital. Brown University,
Providence, Rhode Island
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Results Men Women p value
Angio Reference (mm) 350 3.29 NS
Ultrasound Reference (mm) 337 2.85 0001
Balloon Size (mm) 348 3.27 010
Balloon/Angio RatiO 1.00 1.02 NS
BalloonlUltrasound Ratio 1.06 1.17 005
Intravascular Ultrasound Evidence of Significant
Oversizing of Angioplasty Balloons in Female
Patients
David J. Moliterno, Anthony C. De Franco, E. Murat Tuzcu, Stephen G. Ellis, David
S. Eccleston, Russell E. Raymond, Patrick L. Whitlow, Steven E. Nissen. Cleveland
Clinic, Cleveland, OH
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To gain insight into the strategies and factors influencing the performance of
percutaneous transluminal coronary angioplasty (PTCA) in patients (pts) with
multivessel coronary artery disease, the procedures of the 915 pts assigned
to PTCA in BARI were examined. Within this group, 3,427 angiographically
significant (>50% diameter reduction) lesions were identified. The majority
of pts had two to six angiographically significant lesions. PTCA was intended
for 63.1 % of angiographically significant lesions and was attempted in 92.7%
of the lesions for which it was intended. Multilesion PTCA was performed
in 77.5% of pts and multivessel PTCA in 69.7%. Staging of the PTCA proce-
dures was performed in 17.5% of pts. The number of lesions attempted per
pt ranged from 1-9 with most pts (72.6%) having 2-4 lesions attempted. Of
lesions present, those between 50-95% were most frequently attempted.
Lesions of 99-100% severity and those less than 50% were less likely to be
attempted. Other factors significantly Ip < 0.05) associated with attempting
lesions included proximal vessel location, classification of a lesion as being a
"culprit" or "clinically significant" or type A or B complexity. Lesions in arteries
supplying a small territory or non-viable myocardium were rarely attempted.
Thus in pts with extensive multivessel CAD, PTCA is applied judiciously and
according to a strategy based on individual pt and lesion assessment. An-
giographic anatomic characteristics and the clinical impact of the lesion are
the most influential factors.
Objectives: Although women may have an increased risk of complications
following interventions, the etiology of this gender-related effect remains un-
certain. While oversizing of angioplasty balloons is associated with increased
complications, no angiographic data have demonstrated inappropriate bal-
loon sizing in women.
Methods: We performed intravascular ultrasound and quantitative angiog-
raphy in 124 patients (101 males, 23 females) before and after coronary bal-
loon angioplasty. In 51 patients, balloon angioplasty was the primary ther-
apy, while in 73, balloon dilatation was performed as an adjunct to rotational
or directional atherectomy. Separate core laboratories, blinded to outcome,
measured angiographic and ultrasound dimensions in reference segments
and target lesions.
These important differences in the ratio of balloon to ultrasound vessel
diameter are partially explained by a greater plaque burden at reference sites
in women (ultrasound area reduction of 43.7% vs. 37.6%).
Conclusions: Although balloons were appropriately sized in women
when compared to angiographic diameter, significant oversizing of balloon
catheters in women was apparent when compared to ultrasound reference
segment dimensions. These findings have important clinical implications for
coronary interventions in women.
Effect of Non-target Lesion Events on the
Predictive Value of 6-Month Angiography for Late
(12 Month) Clinical Outcome After PTCA
Ya Chien Chuang, Jeffrey J. Popma, Mane Foegh, William Battle, Marc Schaeffer,
Nina Prunka, Martin B. Leon, Angiopeptin Investigators. Washington Hospital
Center, Washington, DC
To determine whether the observed discordance between late angiographic
and clinical outcomes in clinical restenosis studies (European angiopeptin:
clinical but not angiographic benefit; CAVEAT: angiographic but not clini-
cal benefit) is affected by the occurrence of late non-target lesion events
(death, myocardial infarction [MI). or remote-site revascularization), we re-
viewed the outcomes of 1061 successfully-treated patients «50% stenosis
and no death, MI, CABG or repeat PTCA <14 days) enrolled in the American
"Pulse Spray" Mini-Urokinase Infusion for
Recanalization of Recently Occluded Saphenous
Vein Grafts
The Effect of Preprocedural Intracoronary
Thrombus on Patient Outcome After
Percutaneous Coronary Intervention
William B. Hillegass, E. Magnus Ohman, Mary Ann O'Hanesian, Robert
A. Harrington, David P. Faxon, Donald F. Fortin, Stephen G. Ellis, Richard S. Stack,
David R. Holmes, Robert M. Califf. Duke University Medical Center, Durham, NC
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The outcome of percutaneous coronary interventions in patients with prepro-
cedural angiographic evidence of thrombus at the target lesion is uncertain.
Detailed angiographic and clinical data were prospectively collected from
2,164 patients enrolled in 3 clinical trials with stable and unstable angina un-
dergoing non-emergency percutaneous coronary interventions. Procedural
success «50% final visual stenosis without death or emergency CABGl and
the presence of preprocedural intracoronary thrombus, defined as a discrete
filling defect at the target lesion, were determined by core laboratory review.
Patient age, prior cardiac history, cardiovascular risk factors, and severity of
disease were well matched between patients with and without thrombus.
Outcomes with 95% confidence intervals were:
Infusions of 1,000,000-6,000,000 U of urokinase over 17-70 hours have
been shown to successfully recanalize recently (2-8 weeks) occluded saphe-
nous vein grafts, however, major bleeding complications are common. These
bleeding complications are often related to the systemic fibrinolytic state in-
duced by the large dose of urokinase given during these infusions. In ad-
dition, these infusions often place a strain on the cardiac catheterization
laboratory scheduling due to their lengthy nature. "Pulse spray" infusions
of urokinase have been shown to successfully recanalize peripheral arterial
and graft occlusions using a much lower dose of urokinase over a shorter
period of time. This procedure requires the placement of a multiple side hole
infusion catheter directly in contact with the occlusion followed by frequent
injections or "sprays" of small doses of urokinase until recanalization is com-
plete. We sought to determine if "pulse spray" mini-urokinase infusion would
shorten the duration and decrease the dose of urokinase infusion required
to successfully recanalize recently occluded saphenous vein grafts (SVG).
Methods: Five patients underwent "pulse spray" mini-urokinase infusions
during the last six months. The mean age was 72.4. All had unstable angina.
The mean age of the occlusion was 3.4 weeks (range 2-6). The target vessel
was as follows: SVG-.LCx (3), SVG-.RCA (1), SVG-.LAD (1). Standard an-
gioplasty guiding catheters and guidewires were used. A Roubin® infusion
catheter was used to locally spray the urokinase. Heparin was administered
to maintain the ACT> 300s during the procedure.
Results: All SVG's were successfully recanalized using the "pulse spray"
mini-urokinase infusion. The mean duration of infusion was 52 minutes
(range 40-60). The mean dose of urokinase was 650,000 U (range 500,000-
750,000 U). All residual SVG stenoses then underwent successful PTCA. No
major ischemic (death, CABG, Mil or bleeding complications (bleeding re-
quiring transfusion, vascular repairl occurred.
Conclusion: Thus, "pulse spray" mini urokinase infusions can successfully
recanalize recently occluded saphenous vein grafts using a much lower dose
of urokinase over a shorter period of time than has previously been reported.
Interestingly, major bleedin'g complications also appear to be reduced. A
larger randomized trial will be required to fully evaluate this technique.
Outcomes Stable Angina Unstable Angina
No Thrombus Thrombus
(n ~ 450) (n ~ 1,476) (n ~ 238)
Procedural Success 87% (84-90%) 85% 183-87%) 80% 175-85%)
Abrupt Closure 4% ( 2- 6%) 6%1 5- 7%) 11%17-15%)
In-Hospital
Death <1% 1% 0
MI 5% 3% 5%
CABG 2% 4% 9%
Repeat PTCA 3% 3% 2%
Composite Outcome 6%14-8%) 8% 17-9%) 12%18-16%)
Six-Month Outcome 27% (23-31 %) 29% (27-31 %) 34% 128-40%)
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Conclusions: 1) The angiographic variables considered were not prediclive
of F or Me. 2) Restenosis ocurred more frequenlly in long and non calcified
lesions.
logistic regression manner, the following was obtained:
HeMme Eltchaninoff, Alain C"bier, Rene Koning, Valerie Sicard, Brahim Baala,
Philippe Dequenne, Charles Chan 1, Arthur Tan 1, Brice Letac. Hopital C. Nicolle
(Vacomed Group), Rouen, France; 1 Singapour Hospital, Singapour
Angioscopy has shown to be superior to angiography in detecting intra-
luminal post-PTCA changes. This randomized study was conducted to com-
pare angioscopic results of rotational alherectomy (RA) vs balloon angio-
plasty IBA) in 43 patients with stable angina. Forty five lesions were randomly
assigned to RA (n = 23) or BA (n = 22). We included lesions located 2 cm
distal from the ostium of the vessel and in a straight segment. Restenotic or
graft lesions were excluded from the study. RA consisted in rotablation with
a single burr (75% of coronary diameter) followed by adjunctive BA (mean
total inflation duration ~ 275 ± 145 sec, mean maximal inflation pressure =
5 ± 2 Atm). BA consisted in 2 to 5 balloon inflations Imean lotal inflalion dura-
tion = 356 ± 168 sec, mean maximal inflation pressure: 8 ± 2 Alm). Balloon
size was chosen for a ratio: artery diameter/balloon diameter close to one.
Angioscopy (4.5F lmagecath angioscope) was performed immediately after
the procedure. Abnormal angioscopic findings included the presence of: 1)
flaps, graded from 1 to 3(1: intimal: 2: protruding into ~50% of the lumen:
3: protruding into >50% of the lumen). 2) Ihrombi, graded from 1 to 3 (1: flat
deposits; 2: protruding but non-occlusive: 3: occlusive), 3) subintimal hem-
orrhage. The 2 groups were comparable for clinical data and angiographic
lesion appearance.
Results: Angiography showed comparable results in the 2 groups. Success
rate (residual % diameler stenosis <50%): 91 % vs 92% and final % diam-
eter stenosis using Philips DCI automated OCA: 33 ± 13% vs 30 ± 10%
were similar in RA and BA groups respeclively, as well as rate of dissections
(NHLBI classification): 3 in the RA group (grade A in 1, grade B in 2) com-
pared with 7 in the BA group (grade A in 1, grade B in 5, grade C in 1), (p ~
NS). Nevertheless, on angioscopy, flaps were observed less frequently after
RA(n = 6, 26%lthan afler BA(n = 13, 59%)and were also less severe (grade
1 in 4, grade 2 in 2 and grade 3 in none) than after BA (grade 1 in 4, grade 2
in 4 and grade 3 in 5), (p < 0.05). There was no difference in the incidence
of angioscopic thrombi (4 after RA, 7 after BA) or subintimal hemorrhage (4
after RA. 3 after BA) between the 2 groups. There was no angioscopy-related
complicalions.
Conclusions: On angioscopy, rotational atherectomy wilh adjunctive bal-
loon augioplasty leads to less frequent and less severe intra-luminal abnor-
malities than balloon angioplasty, with less intra-luminal flaps. Whelherthese
findings are of clinical significance remains under invesligation.
Boris D. Nunez, Edward 1. Keelan, Amir Lerman, Stuart T. Higano, Kirk N. Garratt.
Rich A. Nishimura, David R. Holmes Jr.. Mayo Clinic, Rochester, MN
The effects of Rotational Athereclomy (PTCRA) and adjunctive balloon an-
gioplasty on the coronary microcirculation were studied with a Doppler-Flow
wire in 10 patients (Pts) with single discrete subtotal stenoses in one coro-
nary artery (LAD = 5, RCA = 4, LCX = 1).
Methods: TIM I-grade Flow was determined for each vessel. Using a cine
proyeclor equipped with fra me counter, the number of cineframes required
from initiation of the contrast injection 10 opacification of a specified distal
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High-speed Coronary Rotational Atherectomy. Are
Angiographic Factors Predictive of Failure, Major
Complications or Restenosis? A Multivariate
Analysis
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Angiopeptin restenosis study, a randomized restenosis trial of placebo vs bo-
lus subcutaneous angiopeptin (no effect). During the 12-month follow-up pe-
riod, major cardiac events (death [1.2%], Ml [2.7%], or any revascularization
[31.9%II occurred in 34.4% of patients. Target-lesion revascularization (TLRI
(PTCA or CABG based on clinical sites assessment of symptom status and
angiography) was required in 25.4% patients; non-TLR (remote sitesl was
performed in 12.3%. Angiographic follow-up (FUI was obtained ~6 months
after PTCA and quantitative analysis (ImageComm) was performed. A Re-
ceiver Operating Characteristic (ROC) curve was constructed to determine
the predictive value of the FU % stenosis for TLR and any late cardiac event
(Figure). The predictive value of FU % stenosis was higher for TLR 1~50%:
sensitivity, 87%; specificity, 78%) than for any cardiac event(~50% stenosis:
sensitivity, 72%; specificity, 79%). attributable to the occurrence of non-TLR
events. We conclude that: 11 clinical and angiographic outcomes are corre-
lated when TLR is used as an endpoint for clinical restenosis; and 21 non-
target lesion events may contribute to the observed discordance between
angiographic and clinical outcomes within the 12 months following PTCA.
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In order to determine if angiographic factors are predictive of Failure (F). Ma-
jor Complications (Me) or Restenosis (R) after Rotational Atherectomy with
Rotablator, 16 angiographic variables were analyzed in 243 coronary arter-
ies of 228 patients using a multivariate logistic regression technique (quasi
Newton method and maximal probability technique).
F was defined as the impossibility to complete the procedure; MC as the
occurrence of O-wave myocardial infarction, in-hospital death or the need for
emergency bypass graft surgery; R as recurrent ischemia due to an angio-
graphic reduction of the lumen of the culprit vessel within 6 months following
the procedure.
Angiographic variables analized were: 1: Vessel treated. 2: Type of ob-
struction (A-B-C Task Force AHA-ACe). 3: Lesion lenhgth. 4: Lesion eccen-
tricity. 5: Lesion angulation. 6: Lesion calcification. 7: Ostial lesion. 8: Lesion
at a bifurcation. 9: Restenosed lesion. 10: Preprocedural stenosis. 11' Post-
atherectomy stenosis. 12: Final stenosis. 13: Difficult access. 14: Number
of vessels diseased>70% (1 vessel/multiple vessels). 15: Ejection fraction
«40%1>40%).16: Arterial diameter «3 mml>3 mml
Primary success rate was 95.5% (232/243 arteries) and MC rate was 1.7%
(infarction 2 cases and coronary surgery 2 cases, no deaths were recorded).
F occurred in 6 cases.
None of the covariates analized was statistically significant for F or MC. R
was observed in 28.3% of cases and was 1.86 times more likely in longer
lesions (p < 0.03) and 2.54 times more likely in non calcified lesions (p <
0.04). When lesion length and the presence of calcium were associated in a
